Media & Press Updates
Come visit us at AACR annual meeting 2020
March 2, 2020
Visicell will be at AACR's annual meeting to be held on April 24 - 29, 2020 in San Diego to present our latest development on non-invasive, real-time cell tracking technology.
Visicell named a finalist at San Diego Angel Conference 2020
March 2, 2020
After an intense selection process, Visicell earned a spot to compete at the San Diego Angel Conference taking place on March 28. Six finalists will pitch to investors at this main event, with the top company taking home a minimum $200,000 investment.
Visicell technology to be featured at ISEV2020
February 20, 2020
Our collaborators, Drs. Laura Perin and Sargis Sedrakyan from CHLA, will share exciting findings using Visicell technology at this year's ISEV meeting in Philadelphia, May 20-24.
Visicell advanced to the semi-final round of San Diego Angel Conference
February 15, 2020
Visicell, along with eleven other companies has been selected as semifinalists at the 2020 San Diego Angel Conference for a chance to win an investment of $200k.
Quarter-finalists announced for the 2nd annual San Diego Angel Conference
February 3, 2020
Visicell is one of twenty-seven companies advancing to the quarterfinal round of San Diego Angel Conference from a pool of more than 100 startup companies. The winning company will take home a guaranteed $200,000 investment from angels at the main event on March 28.
Introducing the Visicell advisory board
November 22, 2019
Visicell had assembled an accomplished advisory board composed of serial entrepreneurs and stakeholders in the cell therapy industry. An inaugural advisory meeting was held to celebrate this momentous occasion.
Visicell presents at California Institute of Regenerative Medicine
March 6, 2019
Visicell visited California Institute of Regenerative medicine (CIRM) and presented their recent development on non-invasive cell tracking technology. Learn more about CIRM and its patient-centered mission and impact using the link below.
Visicell is now part of Cell Therapy - TRAcking, Circulation, & Safety (CT-TRACS) Committee at HESI
February 28, 2019
Visicell had recently joined HESI CT-TRACS, a global committee with multiple stakeholders ranging from academic institutions, biotechnology/pharmaceutical companies, regulatory bodies, and other non-profit organizations across Americas, EU, and Asia. Visicell will work closely with other members of the committee such as Novartis, Beringer Manheim, Takeda, GE, Memorial Sloan Kettering, CIRM, and FDA…etc, to develop common best practices and standardize methods for evaluating the safety of cell therapy in patients
We always have a story to tell, so check our news section often and contact us if you need more information!